Thumbnail
Access Restriction
Open

Author Freese, Luana ♦ Barros, Helena M. T. ♦ Pierozan, Pollianna Sangalli ♦ Ferigolo, Maristela ♦ Mazoni, Cláudia Galvão ♦ Fernandes, Simone ♦ Moreira, Taís
Source Directory of Open Access Journals (DOAJ)
Content type Text
Publisher Universidade Federal do Rio Grande do Norte
File Format HTM / HTML
Date Created 2013-09-04
Copyright Year ©2008
Language English ♦ Spanish ♦ Portuguese
Subject Domain (in LCC) B ♦ BF1-990
Subject Keyword Drug therapy ♦ Psychology ♦ Therapy ♦ Smoking ♦ Terapia ♦ Tobacco ♦ Farmacoterapia ♦ Philosophy ♦ Tabagismo ♦ Tabaco ♦ Religion
Abstract A cessação do tabagismo traz benefícios à saúde, pois indivíduos que param de fumar evitam a maioria das doenças associadas ao tabaco. Objetiva-se revisar as características fundamentais e eficácia das intervenções farmacológicas e psicossociais para o tratamento dos tabagistas, apresentando dados de revisões tipo meta-análises e de ensaios clínico randomizados. Intervenções farmacológicas como a terapia de reposição de nicotina e a bupropiona e intervenções psicossociais como a terapia cognitivo-comportamental e a intervenção motivacional face a face e por telefone demonstram eficácia. A farmacoterapia aumenta a chance de abstinência em 2 vezes e as intervenções psicossociais face a face ou por telefone em 1,5 a 2,5 vezes em relação a tabagistas recebendo intervenções controles. Estes dados fornecem subsídios para profissionais de saúde decidirem qual o melhor tratamento para o tabagista, informando as intervenções disponíveis, sua eficácia e o benefício de sua utilização.Smoking cessation is associated to health benefits, because individuals who stop smoking will avoid most tobacco-related disorders. Our aim was to review the most important characteristics and the efficacy of the pharmacological and psychossocial treatments available for tobacco smokers, presenting meta-analysis and randomized clinical trials fundamental conclusions. Pharmacological interventions involving nicotine replacement and antidepressant use, with bupropion as the first line agent, and psychossocial interventions involving cognitive behavioral therapies and face-to-face or phone-based motivational interventions are proving to be efficacious. Pharmacotherapies increase two-fold the chance of abstinence and face-to-face or phone-based psychosocial interventions increase the chance of quitting smoking in 1.5 to 2.5 times in comparison to individuals who try to quit smoking by themselves. These data support health professionals to decide the most effective treatment for individual smokers, according to the available interventions tested, their efficacy and the benefits of use.
ISSN 16784669
Age Range 18 to 22 years ♦ above 22 year
Educational Use Research
Education Level UG and PG ♦ Career/Technical Study
Learning Resource Type Article
Publisher Date 2008-08-01
e-ISSN 1413294X
Journal Estudos de Psicologia (Natal)
Volume Number 13
Issue Number 2
Page Count 8
Starting Page 133
Ending Page 140


Source: Directory of Open Access Journals (DOAJ)